A genetic test may predict at an early age those likely to develop osteoporosis. Knowing your risk may allow easy interventions to prevent future fractures.
Continuously monitoring blood sugar levels turns up new evidence to suggest that more people have sharp increases in their blood sugar than expected.
Direct-to-consumer raw genetic data can be inaccurate, resulting in harm to patients and unnecessary costs to the health care system, new research suggests.
Today, diagnosing rare genetic diseases requires slow, educated guesswork, but a team of Stanford experts is automating the process.
Physician assistant student Sara Lynne Wright's uncle has a genetic disease that has helped her, and her entire family, be more accepting.
Stanford researchers use gene editing and stem cell technologies to determine whether to worry — or not — about mysterious genetic test results.
Genetic diversity in the receptor for a key reproductive hormone may help explain why some populations have higher rates of preterm birth than others.
Women with breast cancer are increasingly receiving multigene genetic testing rather than just screening for the BRCA mutations, new research suggests.
A new gene-editing technology enables scientists to make thousands of edits at once and track them with specific barcodes.
Older people are more susceptible to infection, cancer, and autoimmunity than younger people. This may be the result of our immune cells' receiving increasingly random marching orders as we age.
A biobank from the U.K. releases hundreds of thousands of anonymized medical records and genetic data to scientists, who used it to track down new links between genetics and disease.
In a proof-of-principle study, Stanford scientists and colleagues used the CRISPR/Cas9 system to modify genes in coral, suggesting that the tool could one day aid conservation efforts.
Stanford researchers develop a new way to track the growth of diverse tumor types, using gene editing and DNA barcoding.
Stanford’s Cancer Genetics Program helps assess families' hereditary cancer risks and guide patients to make informed choices about prevention and treatment.
The strange skeletal remains of a fetus discovered in Chile have turned up new insights into the genetics of some bone diseases, according to a new study.
A Stanford Medicine article examines CRISPR, the gene-editing technology, and addresses its potential to help with conditions such as sickle-cell disease.
